- Home
- Publications
- Publication Search
- Publication Details
Title
Azithromycin and the microbiota of cystic fibrosis sputum
Authors
Keywords
-
Journal
BMC MICROBIOLOGY
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-30
DOI
10.1186/s12866-021-02159-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Maintenance tobramycin primarily affects untargeted bacteria in the CF sputum microbiome
- (2020) Maria T Nelson et al. THORAX
- The airway microbiome in COPD, bronchiectasis and bronchiectasis‐COPD overlap
- (2020) Pei Yee Tiew et al. Clinical Respiratory Journal
- The airways microbiome of individuals with asthma treated with high and low doses of inhaled corticosteroids
- (2020) Matthew J. Martin et al. PLoS One
- The effects of cycled inhaled aztreonam on the cystic fibrosis (CF) lung microbiome
- (2019) Alya A. Heirali et al. Journal of Cystic Fibrosis
- Deciphering the Ecology of Cystic Fibrosis Bacterial Communities: Towards Systems-Level Integration
- (2019) Annamaria Bevivino et al. TRENDS IN MOLECULAR MEDICINE
- Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis: The Optimize Randomized Trial
- (2018) Nicole Mayer-Hamblett et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- ECFS best practice guidelines: the 2018 revision
- (2018) Carlo Castellani et al. Journal of Cystic Fibrosis
- Sputum microbiota is predictive of long-term clinical outcomes in young adults with cystic fibrosis
- (2018) Nicole Acosta et al. THORAX
- IDTAXA: a novel approach for accurate taxonomic classification of microbiome sequences
- (2018) Adithya Murali et al. Microbiome
- Viral-Bacterial Co-infections in the Cystic Fibrosis Respiratory Tract
- (2018) Megan R. Kiedrowski et al. Frontiers in Immunology
- Macrolide resistance in Pseudomonas aeruginosa : implications for practice
- (2017) James D. Chalmers EUROPEAN RESPIRATORY JOURNAL
- Impact of azithromycin on the clinical and antimicrobial effectiveness of tobramycin in the treatment of cystic fibrosis
- (2017) Dave P. Nichols et al. Journal of Cystic Fibrosis
- Comparison of Oropharyngeal Microbiota from Children with Asthma and Cystic Fibrosis
- (2017) Sébastien Boutin et al. MEDIATORS OF INFLAMMATION
- The effects of inhaled aztreonam on the cystic fibrosis lung microbiome
- (2017) Alya A. Heirali et al. Microbiome
- Longitudinal sampling of the lung microbiota in individuals with cystic fibrosis
- (2017) Fiona J. Whelan et al. PLoS One
- DADA2: High-resolution sample inference from Illumina amplicon data
- (2016) Benjamin J Callahan et al. NATURE METHODS
- Analysis of Lung Microbiota in Bronchoalveolar Lavage, Protected Brush and Sputum Samples from Subjects with Mild-To-Moderate Cystic Fibrosis Lung Disease
- (2016) Deborah A. Hogan et al. PLoS One
- Long-term effects of azithromycin in patients with cystic fibrosis
- (2016) Clémentine Samson et al. RESPIRATORY MEDICINE
- Macrolides, inflammation and the lung microbiome: untangling the web of causality
- (2016) Robert P Dickson et al. THORAX
- Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung
- (2016) Leopoldo N Segal et al. THORAX
- Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response
- (2015) John C Lam et al. BMC INFECTIOUS DISEASES
- The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation
- (2015) Lisa A Carmody et al. Microbiome
- Novel antiviral properties of azithromycin in cystic fibrosis airway epithelial cells
- (2014) Aline Schögler et al. EUROPEAN RESPIRATORY JOURNAL
- Antivirulence activity of azithromycin in Pseudomonas aeruginosa
- (2014) Francesco Imperi et al. Frontiers in Microbiology
- The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial
- (2014) Geraint B Rogers et al. Lancet Respiratory Medicine
- Cystic Fibrosis Pulmonary Guidelines
- (2013) Peter J. Mogayzel et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Factors influencing the acquisition of Stenotrophomonas maltophilia infection in cystic fibrosis patients
- (2013) Sanja Stanojevic et al. Journal of Cystic Fibrosis
- The impact of azithromycin therapy on the airway microbiota in asthma
- (2013) Mariel Slater et al. THORAX
- Effect of Azithromycin on Systemic Markers of Inflammation in Patients With Cystic Fibrosis Uninfected With Pseudomonas aeruginosa
- (2012) Felix Ratjen et al. CHEST
- Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis
- (2012) T.W.V. Daniels et al. Journal of Cystic Fibrosis
- The SILVA ribosomal RNA gene database project: improved data processing and web-based tools
- (2012) Christian Quast et al. NUCLEIC ACIDS RESEARCH
- Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience
- (2012) Franziska Anne Stressmann et al. THORAX
- Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis
- (2011) M. M. Tunney et al. THORAX
- Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory Medications
- (2010) S. Kanoh et al. CLINICAL MICROBIOLOGY REVIEWS
- The Changing Microbial Epidemiology in Cystic Fibrosis
- (2010) J. J. LiPuma CLINICAL MICROBIOLOGY REVIEWS
- Azithromycin induces anti-viral responses in bronchial epithelial cells
- (2010) V. Gielen et al. EUROPEAN RESPIRATORY JOURNAL
- Effect of Azithromycin on Pulmonary Function in Patients With Cystic Fibrosis Uninfected With Pseudomonas aeruginosaA Randomized Controlled Trial
- (2010) Lisa Saiman JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Azithromycin Reduces Exaggerated Cytokine Production by M1 Alveolar Macrophages in Cystic Fibrosis
- (2009) Magali Meyer et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Azithromycin in Pseudomonas aeruginosa Biofilms: Bactericidal Activity and Selection of nfxB Mutants
- (2009) X. Mulet et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Role of Inhaled Corticosteroids in the Management of Cystic Fibrosis
- (2009) Kristie R. Ross et al. PEDIATRIC DRUGS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now